Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 5.45
PHMD's Cash to Debt is ranked higher than
67% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 6.28 vs. PHMD: 5.45 )
PHMD' s 10-Year Cash to Debt Range
Min: 0.04   Max: 111.17
Current: 5.45

0.04
111.17
Equity to Asset 0.73
PHMD's Equity to Asset is ranked higher than
76% of the 358 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. PHMD: 0.73 )
PHMD' s 10-Year Equity to Asset Range
Min: -0.65   Max: 0.89
Current: 0.73

-0.65
0.89
F-Score: 5
Z-Score: 4.90
M-Score: -2.35
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) 9.81
PHMD's Operating margin (%) is ranked higher than
79% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 6.25 vs. PHMD: 9.81 )
PHMD' s 10-Year Operating margin (%) Range
Min: -7398.99   Max: 25.93
Current: 9.81

-7398.99
25.93
Net-margin (%) 8.18
PHMD's Net-margin (%) is ranked higher than
80% of the 366 Companies
in the Global Medical Devices industry.

( Industry Median: 4.82 vs. PHMD: 8.18 )
PHMD' s 10-Year Net-margin (%) Range
Min: -10020.2   Max: 102.49
Current: 8.18

-10020.2
102.49
ROE (%) 11.46
PHMD's ROE (%) is ranked higher than
84% of the 365 Companies
in the Global Medical Devices industry.

( Industry Median: 5.79 vs. PHMD: 11.46 )
PHMD' s 10-Year ROE (%) Range
Min: -320.97   Max: 395.92
Current: 11.46

-320.97
395.92
ROA (%) 8.32
PHMD's ROA (%) is ranked higher than
86% of the 380 Companies
in the Global Medical Devices industry.

( Industry Median: 3.09 vs. PHMD: 8.32 )
PHMD' s 10-Year ROA (%) Range
Min: -167.7   Max: 46.86
Current: 8.32

-167.7
46.86
ROC (Joel Greenblatt) (%) 49.12
PHMD's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 379 Companies
in the Global Medical Devices industry.

( Industry Median: 12.55 vs. PHMD: 49.12 )
PHMD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4787.58   Max: 192.02
Current: 49.12

-4787.58
192.02
Revenue Growth (%) 22.10
PHMD's Revenue Growth (%) is ranked higher than
95% of the 278 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. PHMD: 22.10 )
PHMD' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 140.9
Current: 22.1

0
140.9
EBITDA Growth (%) -4.90
PHMD's EBITDA Growth (%) is ranked higher than
72% of the 249 Companies
in the Global Medical Devices industry.

( Industry Median: -3.70 vs. PHMD: -4.90 )
PHMD' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 65.7
Current: -4.9

0
65.7
EPS Growth (%) -3.50
PHMD's EPS Growth (%) is ranked higher than
73% of the 233 Companies
in the Global Medical Devices industry.

( Industry Median: -2.80 vs. PHMD: -3.50 )
PHMD' s 10-Year EPS Growth (%) Range
Min: 0   Max: 31.9
Current: -3.5

0
31.9
» PHMD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

PHMD Guru Trades in Q1 2013

Paul Tudor Jones 10,300 sh (New)
» More
Q2 2013

PHMD Guru Trades in Q2 2013

Paul Tudor Jones 10,900 sh (+5.83%)
» More
Q3 2013

PHMD Guru Trades in Q3 2013

Joel Greenblatt 10,240 sh (New)
Chuck Royce 5,898 sh (New)
Paul Tudor Jones 10,100 sh (-7.34%)
» More
Q4 2013

PHMD Guru Trades in Q4 2013

Richard Snow 20,935 sh (New)
Paul Tudor Jones 32,200 sh (+218.81%)
Chuck Royce 5,898 sh (unchged)
Joel Greenblatt Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with PHMD

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 Sold Out 0.01%$11.53 - $15.78 $ 14.9514%0
Joel Greenblatt 2013-09-30 New Buy0.01%$14.62 - $16.59 $ 14.95-6%10240
John Burbank 2012-12-31 Sold Out 0.01%$11.18 - $15.05 $ 14.9511%0
John Burbank 2012-09-30 New Buy0.01%$10.93 - $14.55 $ 14.9513%11371
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 17.00
PHMD's P/E(ttm) is ranked higher than
86% of the 231 Companies
in the Global Medical Devices industry.

( Industry Median: 26.70 vs. PHMD: 17.00 )
PHMD' s 10-Year P/E(ttm) Range
Min: 11.28   Max: 234.15
Current: 17

11.28
234.15
P/B 1.80
PHMD's P/B is ranked higher than
76% of the 355 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. PHMD: 1.80 )
PHMD' s 10-Year P/B Range
Min: 0.27   Max: 9.27
Current: 1.8

0.27
9.27
P/S 1.40
PHMD's P/S is ranked higher than
76% of the 372 Companies
in the Global Medical Devices industry.

( Industry Median: 2.74 vs. PHMD: 1.40 )
PHMD' s 10-Year P/S Range
Min: 0.19   Max: 10.55
Current: 1.4

0.19
10.55
PFCF 16.50
PHMD's PFCF is ranked higher than
84% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 27.48 vs. PHMD: 16.50 )
PHMD' s 10-Year PFCF Range
Min: 6.11   Max: 2799.93
Current: 16.5

6.11
2799.93
EV-to-EBIT 10.60
PHMD's EV-to-EBIT is ranked higher than
89% of the 293 Companies
in the Global Medical Devices industry.

( Industry Median: 20.91 vs. PHMD: 10.60 )
PHMD' s 10-Year EV-to-EBIT Range
Min: 2.8   Max: 17.9
Current: 10.6

2.8
17.9

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 9.00
PHMD's Price/Net Current Asset Value is ranked higher than
53% of the 174 Companies
in the Global Medical Devices industry.

( Industry Median: 9.10 vs. PHMD: 9.00 )
PHMD' s 10-Year Price/Net Current Asset Value Range
Min: 7.05   Max: 237.17
Current: 9

7.05
237.17
Price/Tangible Book 2.60
PHMD's Price/Tangible Book is ranked higher than
72% of the 328 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. PHMD: 2.60 )
PHMD' s 10-Year Price/Tangible Book Range
Min: 1.68   Max: 51.82
Current: 2.6

1.68
51.82
Price/DCF (Projected) 1.40
PHMD's Price/DCF (Projected) is ranked higher than
75% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. PHMD: 1.40 )
PHMD' s 10-Year Price/DCF (Projected) Range
Min: 1.2   Max: 27
Current: 1.4

1.2
27
Price/Median PS Value 0.90
PHMD's Price/Median PS Value is ranked higher than
71% of the 338 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. PHMD: 0.90 )
PHMD' s 10-Year Price/Median PS Value Range
Min: 0.19   Max: 62.5
Current: 0.9

0.19
62.5
Price/Graham Number 1.40
PHMD's Price/Graham Number is ranked higher than
82% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. PHMD: 1.40 )
PHMD' s 10-Year Price/Graham Number Range
Min: 1.18   Max: 1.24
Current: 1.4

1.18
1.24
Earnings Yield (Greenblatt) 9.40
PHMD's Earnings Yield (Greenblatt) is ranked higher than
90% of the 279 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. PHMD: 9.40 )
PHMD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.6   Max: 36.3
Current: 9.4

5.6
36.3
Forward Rate of Return (Yacktman) -5.03
PHMD's Forward Rate of Return (Yacktman) is ranked higher than
64% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. PHMD: -5.03 )
PHMD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -48.2   Max: -5.4
Current: -5.03

-48.2
-5.4

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:LA9A.Germany
PhotoMedex, Inc., a Nevada corporation was incorporated in December 30, 2010. The Company is a global skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. It provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne, actinic keratosis (a precursor to certain types of skin cancer) and photo damage. It also offer a professional product line for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. It provides dermatologists, professional aestheticians, and consumers with the equipment and skin care products they need to treat psoriasis, vitiligo, acne, and UV damage, among other skin conditions. Its three main sources of revenue generation form its three business segments: Consumer segment, Physician Recurring segment and Professional segment. The company faces competition from small, closely held, specialized aesthetic device companies, such as Dezac Group, Home Skinovations Ltd., TRIA Beauty, Inc. and LumaTherm Inc. Several public companies, such as Syneron Medical Ltd., Palomar Medical Technologies Inc. and Solta Medical, Inc., is either looking to market or are already marketing consumer aesthetics products. It also faces substantial competition from other manufacturers of surgical laser systems, whose identity varies depending on the medical application for which the surgical system is being used and from traditional surgical methods. Other companies are developing competitive surgical systems and related technologies. The Company's products and research and development activities are regulated by numerous governmental authorities, mainly the FDA and corresponding state and foreign regulatory agencies.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide